Correction: Different formulations of semaglutide and oxidative stress in subjects with type 2 diabetes and MASLD: an open-label, real-life study.

Acta diabetologica2025PMID: 40105914

View on PubMed DOI: 10.1007/s00592-025-02482-7

Authors

Petralli, Giovanni; Del Zoppo, Alice; Rovera, Chiara; Raggi, Francesco; Salvati, Antonio; Moriconi, Diego; Distaso, Mariarosaria; Brunetto, Maurizia Rossana; Solini, Anna